Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The quality of life in Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder and their association with anxiety, depression, fatigue, and disability.
POEMS syndrome with multiple ganglioside/paraneoplastic antibodies misdiagnosed as CIDP: a case report.
Beyond chronological age: biological aging and its relevance for motor and cognitive function in multiple sclerosis.
Regulation of microglial activation by progranulin through the NF-κB pathway in subarachnoid hemorrhage and its effect on white matter injury.
Updated trends in the global prevalence and burden of mental disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Complex emotion recognition in neurological and neurodevelopmental conditions.
Radiofrequency and pulsed magnetic fields attenuate LPS-induced neuroinflammation and demyelination via PI3K/AKT/HIF-1α-mediated neurovascular protection.
Real-World Diagnostic Phenotypes and Treatment Pathways in Trigeminal Pain: A Retrospective Tertiary-Center Cohort-Diagnostic Phenotypes in Trigeminal Pain.
Apolipoprotein E Deficiency Attenuates Neuroinflammatory Responses and Demyelination in Experimental Autoimmune Encephalomyelitis.
Serum neurofilament light chain increases in healthy postpartum: is it subclinical brain damage or neuroplasticity?
Anti-Inflammatory Properties of Curcumin as Add-On Therapy in Patients with MS-Prospective, Comparative, Randomized, Pilot Study.
Associations of Physical Activity, Muscle Mass and Protein-Rich Food Consumption with Functional Fitness in Individuals with Multiple Sclerosis.
Health inequalities in outpatient neurological conditions across a large UK urban population: a retrospective observational study using automated coding.
The effect of linoderm ointment, containing evening primrose oil, phonophoresis on symptoms of peripheral neuropathy in patients with type 2 diabetes.
Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis.
Unmasking the invisible: Correlates and impact of cognitive complaints in MS.
Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort.
Prenatal APPV infection delays cerebellar myelination and alters gene expression dynamics during recovery from congenital tremor in pigs.
Desired clinic characteristics and unmet support needs for adults with multiple sclerosis: A cross-sectional survey.
Subclinical Peripheral Vascular Leakage in Demyelinating Disease-Associated Uveitis.
Kappa free light chain index in multiple sclerosis and other inflammatory CNS diseases: a pilot single-center study from Argentina.
Does depressed mood affect accuracy of perceptions of cognitive function in multiple sclerosis? The role of momentary depressive symptoms in the correspondence between subjective and objective cognition in multiple sclerosis.
Evaluating nipocalimab for the treatment of chronic inflammatory demyelinating polyneuropathy.
Beyond neurology: The case for metabolic phenotyping in multiple sclerosis diagnostic frameworks.
After Parkinson's, does the GLP-1 hypothesis still hold in multiple sclerosis?
Pages
« first
‹ previous
…
979
980
981
982
983
984
985
986
987
…
next ›
last »